The core activity of OrPha Swiss is the development, manufacture and marketing of medicines for rare diseases (Orphan Diseases) and niche areas, particularly in the fields of pulmonary hypertension, infectiology and intensive and emergency medicine.
AI-generated
Offering
Products & services
Industry:Pharmaceutical Industry
✓ Offered4
Medicines for rare diseases
Medicines for drug therapy of rare diseases, supplemented with products for «orphaned» or niche areas of the Swiss market.
Original medicines and selected generics
Product portfolio of original medicines and selected generic drugs, with a healthcare professional access to expanded product information.
Pharmaceutical partnership
Partnerships with treating healthcare professionals, wholesalers, pharmacies, hospital pharmacies and pharmaceutical companies in Switzerland as well as internationally, including support in the development of new products.
Product information for healthcare professionals
Expanded product information for medical healthcare professionals via Swiss RX Login, with access to up-to-date information on the medicines.
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.